N

Neuroplast

29 employees

Neuro-regenerative personalized medicine is one of the most promising therapies, which needs dedicated uniform standards and regulations.

Basic info

biotechnology research

Stem cell technology

Alternative Medicine

Fast-track development programs

Parkinson's disease

Orphan diseases

ALS

MS

GMP - Good Manufacturing Practice

Living medicine

Neuro-Cells (r)

Therapeutics

Spinal cord injury

Traumatic brain injury

Frontotemporal dementia

Neurodegenerative diseases

Regenerative medicine

2014

$11M

from 4 investors over 4 rounds

N

Neuroplast raised $11M on November 17, 2021

Investors: Brightlands Venture Partners and NV Industriebank LIOF

N

Neuroplast raised $4.3M on February 19, 2020

Investors: Brightlands Venture Partners and NV Industriebank LIOF